BREAKING: EDIT Reports Narrower Loss for Q4 EPS, vs. $0.21 per share estimated
Editas Medicine reports Q4 loss of $0.06/share, narrower than the $0.21 consensus estimate.
ADVERTISEMENT
Healthcare
REGENXBIO Q4 2025 Earnings
Financial Performance and Liquidity Revenues for the fourth quarter of 2025 reached $30.3 million, an increase from $21.2 million in...
CorMedix (CRMD) reports higher Q4 2025 net profit on strong revenue growth
Biopharmaceutical company CorMedix Inc. (NASDAQ: CRMD) reported a sharp increase in revenues for the fourth quarter of fiscal 2025, primarily...
Liquidia Corporation (LQDA) swings to profit in Q4 FY25 on strong revenue growth
Biopharmaceutical company Liquidia Corporation (NASDAQ: LQDA) reported a profit for the fourth quarter of fiscal 2025, compared to a loss...
Earnings Summary: EyePoint (EYPT) Q4 2025 net loss widens
EyePoint, Inc. (NASDAQ: EYPT), which is engaged in the development of therapeutics for retinal diseases, on Wednesday announced financial results...
Earnings Summary: National Vision Holdings (EYE) reports 15% growth in Q4 FY25 revenues
Optical retail company National Vision Holdings, Inc. (NASDAQ: EYE) on Wednesday announced financial results for the fourth quarter of FY25,...
Earnings Summary: Cellectar Biosciences (CLRB) FY25 net loss narrows
Cellectar Biosciences, Inc. (NASDAQ: CLRB), a biopharmaceutical company engaged in the discovery and development of cancer drugs, reported a narrower...
Cryoport (CYRX) Set to Report Q4 FY2025 Earnings After the Bell — Here’s What to Expect
Ticker: CYRX | Exchange: NASDAQ | Report Date: March 3, 2026, after market close Cryoport, the specialized cold chain logistics...
Rigel Pharmaceuticals (RIGL) Set to Report Q4 FY2025 Earnings After the Bell — Here’s What to Expect
Ticker: RIGL | Exchange: NASDAQ | Report Date: March 3, 2026, after market close Rigel Pharmaceuticals, a specialty pharma company...
Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens
Zymeworks Inc. (NASDAQ: ZYME), a Canada-based clinical-stage biotechnology company, on Monday reported a wider net loss for the fourth quarter...